Mexiletine Associated With Better Reduction in Muscle Stiffness Than Placebo in Nondystrophic Myotonia
Findings support the efficacy of mexiletine and the potential value of N-of-1 trials for assessing interventions in some chronic rare diseases.
Myotonia
New Scoring System for Predicting Survival in Myotonic Dystrophy Type 1
Age, diabetes, need for support when walking, heart rate, systolic blood pressure, first-degree atrioventricular block, bundle-branch block, and vital lung capacity were all linked to death.
Next post in Neuromuscular Disorders
